Clinical Trial Update: A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis [NA]

View source ↗

Summary

This document reports the completion of a pilot trial evaluating a heparin dosing algorithm for patients undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Vantive Health LLC | Conditions: Renal Failure Chronic Requiring Hemodialysis | NA | Status: COMPLETED